Comparative Pharmacology
Head-to-head clinical analysis: DISOMER versus X TROZINE L A.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DISOMER versus X TROZINE L A.
DISOMER vs X-TROZINE L.A.
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Selective dopamine D2 receptor antagonist; also blocks alpha-1 adrenergic, histamine H1, and muscarinic M1 receptors.
X-TROZINE L.A. is a piperazine derivative that acts as a centrally acting alpha-2 adrenergic agonist, reducing sympathetic outflow from the brainstem, leading to decreased peripheral vascular resistance and lowered blood pressure.
Adults: 1 mg orally once daily.
250 mg orally once daily. May be increased to 500 mg once daily if needed.
None Documented
None Documented
12–15 hours in adults with normal renal function; prolonged to 30–40 hours in severe renal impairment (CrCl <30 mL/min).
12-15 hours; prolonged in renal impairment (up to 30 hours in CrCl <30 mL/min).
Renal: 80% as unchanged drug; biliary/fecal: 15% as metabolites; <5% unchanged in feces.
Primarily renal (70-80% as unchanged drug), with 20-30% fecal via biliary excretion.
Category C
Category C
Antihistamine
Antihistamine